Edwards Lifesciences (Irvine, Calif.) has won FDA approval for a valve-in-valve indication for the Sapien XT. The approval opens up the door for Edwards to address an additional patient population that its rival Medtronic (Dublin) already had access to through its Corevalve Evolut valve. Read More
